DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
F••••• P••••• H•••••••• I••
Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $257M
sum of BDC pieces, a lower bound
Fair value
$250M
98c on cost, debt pieces
Unfunded
$30.4M
commitments not yet drawn
BDC lenders
6
6 on the latest quarter
Facilities
6
0 equity pieces beside them
Next maturity
Nov 6, 2031
no dated debt inside 24 months
On the tape since
Dec 31, 2024
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| other lien unstated | at least $196M | 98c | S+550 bp PIK 2.75% | Nov 6, 2031 | 2 |
| term loan lien unstated | at least $54.5M | n/a | 9.15% | Nov 6, 2031 | 2 |
| first lien term loan first lien | at least $4.9M | 100c | SOFR+550 bp PIK 2.75% | Nov 6, 2031 | 2 |
| revolver lien unstated | at least $1.6M | n/a | 8.66% | Nov 6, 2031 | 4 |
| first lien delayed draw term loan first lien | at least $0 | n/a | SOFR+500 bp | Nov 6, 2031 | 2 |
| delayed draw term loan lien unstated | at least $0 | n/a | Nov 6, 2031 | 4 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••••••••• P•••••• C••••• F••• | unstated lien unstated Non-Affiliated Issuer | $4.2M | $3.8M 95c | S+500 bp |
| B••••••••• P•••••• C••••• F••• | unstated lien unstated Non-Affiliated Issuer | $163M | $158M 98c | S+550 bp PIK 2.75% |
| B••••••••• P•••••• C••••• F••• | revolver lien unstated Revolver | n/a | n/a | |
| B••••••••• P•••••• C••••• F••• | delayed draw term loan lien unstated Delayed Draw Term Loan | n/a | n/a | |
| B••••••••• S•••••• L•••••• F••• | unstated lien unstated Non-Affiliated Issuer | $28.3M | $27.6M 98c | S+550 bp PIK 2.75% |
| B••••••••• S•••••• L•••••• F••• | delayed draw term loan lien unstated Delayed Draw Term Loan | n/a | n/a | |
| B••••••••• S•••••• L•••••• F••• | revolver lien unstated Revolver | n/a | n/a | |
| B••••••••• S•••••• L•••••• F••• | unstated lien unstated Non-Affiliated Issuer | $734,000 | $667,000 95c | S+500 bp |
| J•••••••• C••••• P••••••• B•• I••• | term loan first lien Type First Lien Term Loan Reference Rate and Spread S + 5.50% (includes 2.75% PIK) Maturit | $3.8M | $3.8M 99c | SOFR+550 bp PIK 2.75% |
| J•••••••• C••••• P••••••• B•• I••• | delayed draw term loan first lien Type First Lien Delayed Draw Term Loan Reference Rate and Spread S + 5.00% Maturity Date 1 | $0 | $-21,000 84c | SOFR+500 bp |
| J•••••••• C••••• P••••••• B•• I••• | delayed draw term loan first lien Investment Type First Lien Delayed Draw Term Loan | n/a | $-21,000 | |
| L••• A••••• P•••••• C••••• F••• | revolver lien unstated Revolver) [Member] | $1.2M | $1.1M | 8.66% |
| L••• A••••• P•••••• C••••• F••• | term loan lien unstated Term Loan) [Member] | $36.2M | $35.6M | 9.15% |
| L••• A••••• P•••••• C••••• F••• | delayed draw term loan lien unstated Delayed Draw) [Member] | $0 | $-49,000 | |
| L••• A••••• P•••••• C••••• F••• S• | term loan lien unstated Term Loan) [Member] | $18.3M | $18.0M | 9.15% |
| L••• A••••• P•••••• C••••• F••• S• | delayed draw term loan lien unstated Delayed Draw Term Loan A) [Member] | $0 | $-21,000 | |
| L••• A••••• P•••••• C••••• F••• S• | revolver lien unstated Revolver) [Member] | $499,000 | $467,000 | 8.66% |
| S••••• C••••• I••••••••• L•• | delayed draw term loan first lien Investment Type First Lien Delayed Draw Term Loan | n/a | $-6,000 | |
| S••••• C••••• I••••••••• L•• | delayed draw term loan first lien Type First Lien Delayed Draw Term Loan Reference Rate and Spread S + 5.00% Maturity Date 1 | $0 | $-6,000 -600c | SOFR+500 bp |
| S••••• C••••• I••••••••• L•• | term loan first lien Type First Lien Term Loan Reference Rate and Spread S + 5.50% (includes 2.75% PIK) Maturit | $1.1M | $1.1M 100c | SOFR+550 bp PIK 2.75% |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 6 | $257M | $250M | 126c | 4 |
| Mar 31, 2026 | 5 | $199M | $197M | 100c | 4 |
| Dec 31, 2025 | 6 | $254M | $252M | 127c | 0 |
| Sep 30, 2025 | 4 | $197M | $195M | 100c | 0 |
| Jun 30, 2025 | 2 | $153M | $151M | 100c | 0 |
| Mar 31, 2025 | 2 | $149M | $148M | 100c | 0 |
| Dec 31, 2024 | 2 | $196M | $192M | 100c | 0 |
What changed
- PIK interest appearsMar 31, 2026
- Spread increasedMar 31, 2026
- Spread increasedMar 31, 2026
- Spread increasedMar 31, 2026
- Spread increasedMar 31, 2026
- PIK interest appearsMar 31, 2026
- PIK interest appearsMar 31, 2026
- PIK interest appearsMar 31, 2026
- PIK interest appearsMar 31, 2026
- New lender joined a facilityDec 31, 2025
- New lender joined a facilityDec 31, 2025
- New lender joined a facilityDec 31, 2025
- New lender joined a facilityDec 31, 2025
- New borrower on a BDC scheduleDec 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- FALCONderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 6 BDCsderived
- Industry
- Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it